Struthers Richard Scott (CIK 0001746298)

Latest company ownership

Shares held
1,192,222
Last filed at
Sep 30, 2025
Confidence Score
49.9
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 26, 2025 Sep 30, 2025 Crinetics Pharmaceuticals, Inc. CEO Sell 48.8 -4,000 -0.31% $180K
Mar 19, 2025 Mar 21, 2025 Crinetics Pharmaceuticals, Inc. CEO Sell 42.5 -17,338 -1.40% $593K
Dec 2, 2024 Dec 4, 2024 Crinetics Pharmaceuticals, Inc. CEO Sell 45.0 -10,000 -0.86% $575.7K
May 8, 2024 May 10, 2024 Crinetics Pharmaceuticals, Inc. CEO Sell 22.5 -107,448 -8.48% $5.3M
Apr 4, 2024 Apr 8, 2024 Crinetics Pharmaceuticals, Inc. CEO Sell 32.5 -40,951 -3.47% $2M
Mar 18, 2024 Mar 20, 2024 Crinetics Pharmaceuticals, Inc. CEO Sell 42.5 -12,687 -1.10% $483.9K
Nov 2, 2023 Nov 6, 2023 Crinetics Pharmaceuticals, Inc. CEO Sell 16.3 -200,000 -14.57% $6.1M
Jul 11, 2023 Jul 13, 2023 Crinetics Pharmaceuticals, Inc. CEO Sell 17.5 -50,000 -4.64% $1M
Jun 16, 2023 Jun 21, 2023 Crinetics Pharmaceuticals, Inc. CEO Sell 17.5 -50,000 -4.44% $1M
Mar 16, 2023 Mar 17, 2023 Crinetics Pharmaceuticals, Inc. CEO Sell 48.8 -4,628 -0.41% $79.2K
Apr 13, 2022 Apr 15, 2022 Crinetics Pharmaceuticals, Inc. CEO Sell 20.0 -138,643 -11.57% $3.7M
Apr 5, 2022 Apr 7, 2022 Crinetics Pharmaceuticals, Inc. CEO Sell 42.5 -21,357 -1.75% $541.2K
Sep 7, 2021 Sep 9, 2021 Crinetics Pharmaceuticals, Inc. CEO Sell 38.8 -30,000 -2.51% $750K
Dec 2, 2020 Dec 4, 2020 Crinetics Pharmaceuticals, Inc. CEO Buy 65.0 +5,000 0.42% $65K
Jul 15, 2020 Jul 17, 2020 Crinetics Pharmaceuticals, Inc. CEO Sell 20.0 -35,000 -2.86% $520.8K